JPH03219887A - Production of stereptovaricin - Google Patents
Production of stereptovaricinInfo
- Publication number
- JPH03219887A JPH03219887A JP1428590A JP1428590A JPH03219887A JP H03219887 A JPH03219887 A JP H03219887A JP 1428590 A JP1428590 A JP 1428590A JP 1428590 A JP1428590 A JP 1428590A JP H03219887 A JPH03219887 A JP H03219887A
- Authority
- JP
- Japan
- Prior art keywords
- streptovaricin
- adsorbent
- medium
- producing
- nonionic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 18
- JDECNKBYILMOLE-CJQFIEQYSA-N chembl1255887 Chemical compound O1COC(=C(C)C2=O)C3=C1\C(C)=C\[C@@](C)(O)[C@H](O)[C@@H](C)[C@@H](O)[C@H](C(=O)OC)[C@H](O)[C@H](C)[C@H](O)[C@H](C)\C=C/C=C(C)/C(=O)NC1=C(C)C(OC(C)=O)=C3C2=C1O JDECNKBYILMOLE-CJQFIEQYSA-N 0.000 claims abstract description 41
- 239000003463 adsorbent Substances 0.000 claims abstract description 32
- 229930184317 Streptovaricin Natural products 0.000 claims abstract description 27
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims abstract description 17
- 238000012258 culturing Methods 0.000 claims abstract description 9
- 239000001530 fumaric acid Substances 0.000 claims abstract description 8
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims abstract description 8
- 150000003839 salts Chemical class 0.000 claims description 8
- 241000894006 Bacteria Species 0.000 claims description 5
- 241000187747 Streptomyces Species 0.000 claims description 4
- 239000002609 medium Substances 0.000 abstract description 27
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 abstract description 5
- 239000001963 growth medium Substances 0.000 abstract description 5
- 241000970875 Streptomyces spectabilis Species 0.000 abstract description 4
- 239000000126 substance Substances 0.000 abstract description 4
- 239000001747 Potassium fumarate Substances 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 3
- 229910052757 nitrogen Inorganic materials 0.000 abstract description 3
- SHPKCSFVQGSAJU-SEPHDYHBSA-L potassium fumarate Chemical compound [K+].[K+].[O-]C(=O)\C=C\C([O-])=O SHPKCSFVQGSAJU-SEPHDYHBSA-L 0.000 abstract description 3
- 235000019295 potassium fumarate Nutrition 0.000 abstract description 3
- 229920003002 synthetic resin Polymers 0.000 abstract description 3
- 239000000057 synthetic resin Substances 0.000 abstract description 3
- 238000005406 washing Methods 0.000 abstract description 3
- CHRJZRDFSQHIFI-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;styrene Chemical compound C=CC1=CC=CC=C1.C=CC1=CC=CC=C1C=C CHRJZRDFSQHIFI-UHFFFAOYSA-N 0.000 abstract description 2
- 235000015278 beef Nutrition 0.000 abstract description 2
- 238000010828 elution Methods 0.000 abstract description 2
- 239000002245 particle Substances 0.000 abstract description 2
- 239000011148 porous material Substances 0.000 abstract description 2
- 238000010898 silica gel chromatography Methods 0.000 abstract description 2
- 239000004215 Carbon black (E152) Substances 0.000 abstract 1
- 229930195733 hydrocarbon Natural products 0.000 abstract 1
- 150000002430 hydrocarbons Chemical class 0.000 abstract 1
- 238000000855 fermentation Methods 0.000 description 16
- 230000004151 fermentation Effects 0.000 description 16
- JDECNKBYILMOLE-BNUPKYPQSA-N streptovaricinoic acid methyl ester Natural products COC(=O)C1C(O)C(C)C(O)C(C)C=C/C=C(C)/C(=O)Nc2c(C)c(OC(=O)C)c3C4=C(OCOC4=C(C)C(=O)c3c2O)C(=CC(C)(O)C(O)C(C)C1O)C JDECNKBYILMOLE-BNUPKYPQSA-N 0.000 description 14
- 238000000034 method Methods 0.000 description 13
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 12
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 8
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 6
- 235000013312 flour Nutrition 0.000 description 6
- 239000003960 organic solvent Substances 0.000 description 6
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 244000068988 Glycine max Species 0.000 description 5
- 235000010469 Glycine max Nutrition 0.000 description 5
- 239000004793 Polystyrene Substances 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- 239000012046 mixed solvent Substances 0.000 description 5
- 229920002223 polystyrene Polymers 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 4
- 239000001744 Sodium fumarate Substances 0.000 description 4
- 229910000019 calcium carbonate Inorganic materials 0.000 description 4
- 235000010216 calcium carbonate Nutrition 0.000 description 4
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 4
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 4
- 235000019797 dipotassium phosphate Nutrition 0.000 description 4
- MSJMDZAOKORVFC-SEPHDYHBSA-L disodium fumarate Chemical compound [Na+].[Na+].[O-]C(=O)\C=C\C([O-])=O MSJMDZAOKORVFC-SEPHDYHBSA-L 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 229940005573 sodium fumarate Drugs 0.000 description 4
- 235000019294 sodium fumarate Nutrition 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 240000008042 Zea mays Species 0.000 description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 235000005822 corn Nutrition 0.000 description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 3
- 235000019341 magnesium sulphate Nutrition 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 2
- 101100313763 Arabidopsis thaliana TIM22-2 gene Proteins 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 230000002365 anti-tubercular Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 229920001429 chelating resin Polymers 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- -1 malt extract Substances 0.000 description 2
- 125000001477 organic nitrogen group Chemical group 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 229910000160 potassium phosphate Inorganic materials 0.000 description 2
- 235000011009 potassium phosphates Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000011218 seed culture Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 235000019733 Fish meal Nutrition 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- PBCJIPOGFJYBJE-UHFFFAOYSA-N acetonitrile;hydrate Chemical compound O.CC#N PBCJIPOGFJYBJE-UHFFFAOYSA-N 0.000 description 1
- 125000005396 acrylic acid ester group Chemical group 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- APUPEJJSWDHEBO-UHFFFAOYSA-P ammonium molybdate Chemical compound [NH4+].[NH4+].[O-][Mo]([O-])(=O)=O APUPEJJSWDHEBO-UHFFFAOYSA-P 0.000 description 1
- 239000011609 ammonium molybdate Substances 0.000 description 1
- 235000018660 ammonium molybdate Nutrition 0.000 description 1
- 229940010552 ammonium molybdate Drugs 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- GVPFVAHMJGGAJG-UHFFFAOYSA-L cobalt dichloride Chemical compound [Cl-].[Cl-].[Co+2] GVPFVAHMJGGAJG-UHFFFAOYSA-L 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 229960001781 ferrous sulfate Drugs 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 239000004467 fishmeal Substances 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- OTWCRNWNFLGDTC-SEPHDYHBSA-L potassium;sodium;(e)-but-2-enedioate Chemical compound [Na+].[K+].[O-]C(=O)\C=C\C([O-])=O OTWCRNWNFLGDTC-SEPHDYHBSA-L 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 230000001177 retroviral effect Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 235000020712 soy bean extract Nutrition 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は、高い生産効率を有するストレプトバリシンの
製造方法に関する。DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to a method for producing streptovaricin with high production efficiency.
ストレプトバリシンは、主にA、B、C,DおよびEの
5種からなり、当初抗結核抗生物質としての有用性が注
目され、最近になってこれを化学変性して得られる誘導
体が抗レトロウィルス剤、抗癌剤等として有用であるこ
とが判明し注目されるに到っている(例えば、特開昭5
4−110000号公報参照)。このような有用誘導体
はストレプトバリシンCから誘導されているため、スト
、レプトバリシンCが特に注目されている。Streptovaricin is mainly composed of five types, A, B, C, D and E, and initially attracted attention for its usefulness as an anti-tuberculous antibiotic. Recently, a derivative obtained by chemically modifying it has been developed as an anti-tuberculous antibiotic. It has been found to be useful as a retroviral agent, anticancer agent, etc., and has attracted attention (for example,
(See Publication No. 4-110000). Since such useful derivatives are derived from streptovaricin C, streptovaricin C has attracted particular attention.
従来、かかるストレプトバリシンの製造方法としては、
ストレプトマイセス・スペクタビリスの深部培養により
発酵生産する方法が知られているしかし、上記の従来の
製造方法は生産効率が低く、極めて少量のストレプトバ
リシンしか得られない。そのため、工業的には実用化は
困難であるという欠点を有する。上記従来の方法におい
ては、生産されたストレプトバリシンが培地中で速やか
に分解されることが判明したほか、生産されたストレプ
トバリシンが脂溶性が高いために菌糸表面に蓄積し生産
抑制を引き起こすためと考えられる。Conventionally, the method for producing streptovaricin is as follows:
A method of fermentation production using deep culture of Streptomyces spectabilis is known. However, the above-mentioned conventional production method has low production efficiency and only a very small amount of streptovaricin can be obtained. Therefore, it has the disadvantage that it is difficult to put it into practical use industrially. In the conventional method described above, it has been found that the produced streptovaricin is rapidly degraded in the culture medium, and because the produced streptovaricin is highly fat-soluble, it accumulates on the hyphal surface, causing production suppression. It is thought that this is because of this.
そこで、本発明の目的は、従来の方法を改良し、ストレ
プトバリシンを高い生産効率で製造することができる製
造方法を提供することにある。Therefore, an object of the present invention is to improve the conventional method and provide a production method that can produce streptovaricin with high production efficiency.
すなわち、本発明は、上記の従来の方法の問題点を解決
するものとして、
ストレプトマイセス属に属するストレプトバリシン生産
菌を、非イオン性吸着剤の存在下で培養する工程を有す
るストレプトバリシンの製造方法を提供するものである
。That is, the present invention solves the problems of the above-mentioned conventional methods, and provides a method for producing streptovaricin, which comprises a step of culturing streptovaricin-producing bacteria belonging to the genus Streptomyces in the presence of a nonionic adsorbent. The present invention provides a method for manufacturing.
微生物
本発明の方法に用いられるストレプトマイセス属に属す
るストレプトバリシン生産菌としては、例えば、ストレ
プトマイセス・スペクタビリス(ATCC27465の
寄託No、でATCCから入手できる)が挙げられる。Microorganisms Streptovaricin-producing bacteria belonging to the genus Streptomyces used in the method of the present invention include, for example, Streptomyces spectabilis (available from ATCC under deposit number ATCC 27465).
非イオン性吸着剤
本発明の方法によると、上記細菌の培養により生産され
たストレプトバリシンは速やかに非イオン性吸着剤に移
行し貯蔵される結果、培地中で分解され難く、また菌糸
表面に蓄積され難いので菌の活性を抑制することが少な
い。その結果、効率よくストレプトバリシンの生産が持
続される。Non-ionic adsorbent According to the method of the present invention, streptovaricin produced by culturing the bacteria described above is quickly transferred to the non-ionic adsorbent and stored. Since it is difficult to accumulate, it rarely inhibits bacterial activity. As a result, streptovaricin production is maintained efficiently.
かかる非イオン性吸着剤としては、比表面積が大きい、
種々の合成樹脂、例えばスチレン、ジビニルベンゼン、
アクリル酸エステル等の1種または2種以上の化合物の
重合体からなる多孔質微粒子を用いることができる。具
体例としては、スチレン−ジビニルベンゼン系合成樹脂
からなる吸着剤、例えば)IP−10,8P−20,H
P−30,HP、40. HP−50(商品名、三菱化
成工業■製)、アンバーライトXAD−2,XAD−4
(商品名、D−A・7ン)’・ハ7ス社製)、アクリル
酸エステル系樹脂からなる吸着剤、例えばアンバーライ
トXAD−7(商品名、ローム・アンド・ハース社製)
等を挙げることができる。このような非イオン性吸着剤
のなかでも、特に好ましいものは、粒径50〜1.00
0μm1比表面積50〜1.000 m’/ g 、細
孔容積0.2〜1.5m/gのものである。前記の市販
品では、例えばHP−20゜XAD−4等が挙げられる
が、これらに特に限定されるものではない。Such nonionic adsorbents have a large specific surface area,
Various synthetic resins, such as styrene, divinylbenzene,
Porous fine particles made of a polymer of one or more compounds such as acrylic esters can be used. Specific examples include adsorbents made of styrene-divinylbenzene synthetic resins, such as IP-10, 8P-20, H
P-30, HP, 40. HP-50 (product name, manufactured by Mitsubishi Chemical Industries, Ltd.), Amberlite XAD-2, XAD-4
(trade name, D-A7', manufactured by Ha7s), adsorbents made of acrylic acid ester resins, such as Amberlite XAD-7 (trade name, manufactured by Rohm and Haas)
etc. can be mentioned. Among such nonionic adsorbents, particularly preferable ones have a particle size of 50 to 1.00.
It has a specific surface area of 0 μm/1, 50 to 1.000 m'/g, and a pore volume of 0.2 to 1.5 m/g. Examples of the commercially available products include HP-20°XAD-4, but are not particularly limited thereto.
本発明の方法の実施においては、非イオン性吸着剤は、
発酵の開始後でもよいが、通常、菌を発酵培地に接種す
る前に培地に添加するのが好ましい。培地への添加量は
、0.1〜20%程度が適当であり、さらには0.5〜
10%が好ましい。In carrying out the method of the invention, the nonionic adsorbent is
Although it may be added after the start of fermentation, it is usually preferable to add it to the fermentation medium before inoculating the bacteria into the fermentation medium. The appropriate amount to add to the medium is about 0.1 to 20%, more preferably 0.5 to 20%.
10% is preferred.
好適な態様
本発明の方法を実施する際には、培地にさらにフマル酸
およびその水溶性塩から選ばれる少なくとも1種をも前
記の非イオン性吸着剤を含む培地に添加し共存させるこ
とが好ましい。フマル酸やその塩を培地に添加すること
によって、ストレプトバリシン、特に有用性の高いスト
レプトバリシンCの生産が促進され、生産量がさらに高
まる。Preferred Embodiments When carrying out the method of the present invention, it is preferable that at least one kind selected from fumaric acid and its water-soluble salts is further added to the medium containing the nonionic adsorbent and allowed to coexist. . By adding fumaric acid or its salt to the medium, the production of streptovaricin, especially streptovaricin C, which is highly useful, is promoted and the production amount is further increased.
用いることができる水溶性塩どしては、例えば、フマル
酸カリウム、フマル酸ナトリウム、フマル酸カリウムナ
トリウム、フマル酸−カリウム、フマル酸−ナトリウム
等が挙げられる。フマル酸および上に例示のフマル酸塩
は、1種単独でも2種以上を組み合わせても使用するこ
とができる。Examples of water-soluble salts that can be used include potassium fumarate, sodium fumarate, potassium sodium fumarate, potassium fumarate, and sodium fumarate. Fumaric acid and the fumarate salts exemplified above can be used alone or in combination of two or more.
フマル酸またはその水溶性塩の培地への添加量は、フマ
ル酸として培地に対し0.1〜10%、さらに0.5〜
5%程度が好ましい。このフマル酸またはその塩も、培
地に発酵前に添加してもよいし、発酵開始後に添加ある
いは追加してもよいが、通常は発酵開始前に添加してお
くのがよい。The amount of fumaric acid or its water-soluble salt added to the medium is 0.1 to 10%, and further 0.5 to 10% of the medium as fumaric acid.
About 5% is preferable. This fumaric acid or its salt may also be added to the medium before fermentation or after the start of fermentation, but it is usually better to add it before the start of fermentation.
その他の培養条件
本発明の方法に用いられる培地その他の条件には特に制
限はなく、微生物の培養により抗生物質等を製造する際
に通常用いられる条件を用いることができる。すなわち
、窒素源、資化性炭素源および無機塩を含む水性培地を
用い、好気的条件下で深部培養を行うのが一般的である
。Other Culture Conditions There are no particular limitations on the culture medium and other conditions used in the method of the present invention, and conditions commonly used when producing antibiotics and the like by culturing microorganisms can be used. That is, it is common to perform deep culture under aerobic conditions using an aqueous medium containing a nitrogen source, an assimilable carbon source, and an inorganic salt.
窒素源としては無機、有機のいずれも用いることができ
、例えば牛肉エキス、ペプトン、大豆粉等の植物性タン
パク質、カゼイン、麦芽エキス、魚粉、綿粉、ケイソイ
(脱脂大豆微粉末)、落花生粉、醸造用酵母、コーン
グルテン粉、コーンスチープリカー等の有機窒素源;硫
酸アンモニウム、硝酸アンモニウム、硝酸カリウム等の
無機窒素源が挙げられる。Both inorganic and organic nitrogen sources can be used, such as beef extract, peptone, vegetable proteins such as soybean flour, casein, malt extract, fish meal, cotton flour, keiso (defatted fine soybean powder), peanut flour, Examples include organic nitrogen sources such as brewer's yeast, corn gluten flour, and corn steep liquor; and inorganic nitrogen sources such as ammonium sulfate, ammonium nitrate, and potassium nitrate.
資化性炭素源としては、例えばグルコース、デキストリ
ン、糖蜜、スターチ、マルトース、ガラクトース、マン
ニトール、蔗糖、乳糖、大豆油等が挙げられる。Examples of assimilable carbon sources include glucose, dextrin, molasses, starch, maltose, galactose, mannitol, sucrose, lactose, and soybean oil.
栄養無機塩類としては、例えばす) IJウム、カルシ
ウム、燐酸根、硫酸根等のイオンを生じる塩類が挙げら
れ、具体的には、炭酸カルシウム、燐酸カリウム、硫酸
マグネシウム、塩化カリウム、塩化す) IJウム、硫
酸亜鉛、硫酸第一鉄、硫酸マンガン、塩化コバルト、モ
リブデン酸アンモニウム等がある。Examples of nutrient inorganic salts include salts that produce ions such as IJ, calcium, phosphate, and sulfate, specifically, calcium carbonate, potassium phosphate, magnesium sulfate, potassium chloride, and IJ chloride. These include zinc sulfate, ferrous sulfate, manganese sulfate, cobalt chloride, and ammonium molybdate.
培養における、培地のpt(は5.5〜7.5程度が適
当であり、温度は23〜37℃、特に25〜30℃の範
囲が適当で、およそ4〜8日程度の培養によって最大収
量が得られる。In culture, the appropriate pt (pt) of the medium is about 5.5 to 7.5, the temperature is preferably 23 to 37°C, especially 25 to 30°C, and the maximum yield can be achieved by culturing for about 4 to 8 days. is obtained.
ストレプトバリシンの採取
本発明の方法によると、発酵により生産されたストレプ
トバリシンは非イオン性吸着剤に吸着された形で得られ
るので、非イオン性吸着剤を培地から分離したのち、ス
トレプトバリシンを非イオン性吸着剤から分離する必要
がある。Collection of streptovaricin According to the method of the present invention, streptovaricin produced by fermentation is obtained in the form of being adsorbed to a nonionic adsorbent. It is necessary to separate syn from non-ionic adsorbents.
非イオン性吸着剤を培地から分離するには、例えば、網
等を用いて濾別する方法、非イオン性吸着剤と培地との
比重差を利用する方法(具体的には、例えば、一定濃度
の食塩水に発酵後の発酵培地を投入する方法、遠心分離
機を用いる方法等)などが挙げられる。In order to separate the nonionic adsorbent from the medium, for example, there is a method of filtering it using a net, etc., a method of utilizing the difference in specific gravity between the nonionic adsorbent and the medium (specifically, for example, Examples include a method of adding the fermentation medium after fermentation to a saline solution, a method of using a centrifuge, etc.).
非イオン性吸着剤からストレプトバリシンを分離するに
は、適当な有機溶剤または有機溶剤と水との混合溶剤を
溶出剤として用い、培地から回収された非イオン性吸着
剤を洗浄することにより、吸着剤に吸着しているストレ
プトバリシンを溶出させればよい。用いられる有機溶剤
としては、例えばメタノール、エタノール、アセトン、
アセトニトリル、酢酸エチル、ジクロロエタン1.クロ
ロホルム等、またはこれらの2種以上の混合溶剤;これ
ら有機溶剤の1種もしくは2種以上と水との混合溶剤な
どが挙げられる。ストレプトバリシンを効果的に溶出さ
せるには、第1に、有機溶剤濃度の低い水溶液でストレ
プトバリシンが吸着された吸着剤を洗浄し、次に有機溶
剤濃度の高い水溶液で洗浄するのが好ましい。To separate streptovaricin from the nonionic adsorbent, the nonionic adsorbent recovered from the culture medium is washed using a suitable organic solvent or a mixed solvent of organic solvent and water as an eluent. The streptovaricin adsorbed on the adsorbent may be eluted. Examples of organic solvents used include methanol, ethanol, acetone,
Acetonitrile, ethyl acetate, dichloroethane 1. Examples include chloroform or a mixed solvent of two or more thereof; a mixed solvent of one or more of these organic solvents and water. In order to effectively elute streptovaricin, it is preferable to first wash the adsorbent on which streptovaricin has been adsorbed with an aqueous solution with a low organic solvent concentration, and then wash it with an aqueous solution with a high organic solvent concentration. .
発酵により得られるストレプトバリシンの中でもストレ
プトバリシンCが最も有用性が高いので、吸着剤から分
離する際にはストレプトバリシンCを選択的に分離でき
ることが望ましい。このためには、アセトニトリル−水
混合溶媒が好ましい。Among the streptovaricins obtained by fermentation, streptovaricin C is the most useful, so it is desirable to be able to selectively separate streptovaricin C when separating it from the adsorbent. For this purpose, an acetonitrile-water mixed solvent is preferred.
得られたストレプトバリシンは、例えば再結晶の繰り返
し、シリカゲルカラムクロマトグラフィー等によりさら
に精製することができる。The obtained streptovaricin can be further purified, for example, by repeated recrystallization, silica gel column chromatography, etc.
次に本発明を実施例により具体的に説明する。 Next, the present invention will be specifically explained using examples.
実施例I N−ZアミンA 1.25g、グルコース0.63g。Example I NZ amine A 1.25g, glucose 0.63g.
大豆酵素分解エキス0.63g、燐酸−カリウム0.1
6g、燐酸二カリウム0.16gおよび蒸留水100証
を混合してつくった種培地を含む500m1−振盪フラ
スコ内にストレプトマイセス・スペクタビリスATCC
27465株の培養菌を接種した。このフラスコを回転
振盪器に装填し、27℃、20Orpmの条件で72時
間培養し、種培養体を得た。Enzymatic soybean extract 0.63g, potassium phosphate 0.1
Streptomyces spectabilis ATCC in a 500 ml shake flask containing a seed medium prepared by mixing 6 g of dipotassium phosphate, 0.16 g of dipotassium phosphate, and 100% distilled water.
A culture of 27465 strains was inoculated. This flask was loaded into a rotary shaker and cultured at 27° C. and 20 rpm for 72 hours to obtain a seed culture.
次に、脱脂大豆粉末1g、コーンスチーブリ力−181
コーンスターチ2g、ビール酵母0.25g。Next, 1 g of defatted soybean powder, Corn Stieble force -181
2g cornstarch, 0.25g brewer's yeast.
塩化カリウム0.3g、炭酸カルシウム0.4gおよび
蒸留水100mfを混合して調製した前培養培地を含む
500 ml−振盪フラスコ内に前記の種培養体2−を
接種した。次に、このフラスコを回転振盪器に装着し、
27℃、20Orpmの条件で回転させながら48時間
培養を行い、前培養体を得た。The above seed culture 2- was inoculated into a 500 ml shaking flask containing a preculture medium prepared by mixing 0.3 g of potassium chloride, 0.4 g of calcium carbonate, and 100 mf of distilled water. Next, attach this flask to a rotary shaker,
Culture was carried out for 48 hours under the conditions of 27° C. and 20 rpm to obtain a preculture.
次に、こうして得た前培養体5証を、予め500m1−
振盪フラスコ内に調製しておいた、大豆粉48、グルコ
ース4g、ビール酵母0.25g、塩化ナトリウム0.
3g、炭酸カルシウム0.05g、 硫酸マグネシウム
0.25g、燐酸−水素カリウム0.25g、ポリスチ
レン系吸着剤(商品名;ダイヤイオンHP20) 3g
および蒸留水100 dを混合してなる発酵培地に接種
した。このフラスコを回転振盪器に装着し、28℃で6
日間培養した。その後、培養液を網を用いて濾し、前記
の吸着剤を分離した。この吸着−剤をエチルアルコール
−酢酸エチル(1:1)混合溶剤で洗浄し、吸着されて
いる物質を溶出させた。洗浄後の溶剤を高圧液体クロマ
トグラフィーに供したところ、ストレプトバリシンCが
0.4mg含まれていることが確g忍された。Next, 500 ml of the preculture obtained in this way was prepared in advance.
Prepared in a shaking flask were 48 g of soybean flour, 4 g of glucose, 0.25 g of brewer's yeast, and 0.0 g of sodium chloride.
3g, calcium carbonate 0.05g, magnesium sulfate 0.25g, potassium hydrogen phosphate 0.25g, polystyrene adsorbent (product name: Diaion HP20) 3g
and 100 d of distilled water were inoculated into a fermentation medium. This flask was attached to a rotary shaker and heated to 28°C for 6 hours.
Cultured for 1 day. Thereafter, the culture solution was filtered using a mesh to separate the adsorbent. This adsorbent was washed with a mixed solvent of ethyl alcohol and ethyl acetate (1:1) to elute the adsorbed substances. When the washed solvent was subjected to high pressure liquid chromatography, it was confirmed that it contained 0.4 mg of streptovaricin C.
比較例1
発酵培地としてポリスチレン系吸着剤を含まない以外は
同一組成の培地を使用した以外は、実施例1と同様にし
て培養を行い、ストレプトバリシンCを培地および菌体
から分離した。ストレプトバリシンCが0.05mg得
られた。Comparative Example 1 Culture was carried out in the same manner as in Example 1, except that a medium having the same composition but not containing a polystyrene adsorbent was used as the fermentation medium, and streptovaricin C was separated from the medium and the bacterial cells. 0.05 mg of streptovaricin C was obtained.
実施例2
発酵培地として、さらにフマル酸−ナトリウム1.2g
を含む以外は実施例1で用いたものを同一組成の培地、
すなわち大豆粉4g、グルコース4g1ビール酵母0.
25g1塩化ナトリウム0.3g、炭酸カルシウム0.
05g、硫酸マグネシウム0.25g。Example 2 As a fermentation medium, additionally 1.2 g of sodium fumarate
A medium with the same composition as that used in Example 1 except that it contains
That is, 4 g of soybean flour, 4 g of glucose, 0.0 g of brewer's yeast.
25g 1 sodium chloride 0.3g, calcium carbonate 0.
05g, magnesium sulfate 0.25g.
燐酸−水素カリウム0.25g、フマル酸−ナトリウム
1.2g、ポリスチレン系吸着剤(商品名:ダイヤイオ
ンHP20) 3gおよび蒸留水100−を混合してな
る培地を使用した以外は、実施例1と同様にして培養を
行い、ストレプトバリシンCを培地から分離した吸着剤
から実施例1の場合と同じ溶剤で分離した。洗浄後の溶
剤には、ストレプトバリシンCが3.6mg含まれてい
ることが確認された。Example 1 except that a medium prepared by mixing 0.25 g of potassium hydrogen phosphate, 1.2 g of sodium fumarate, 3 g of polystyrene adsorbent (trade name: Diaion HP20) and 100 g of distilled water was used. Culture was carried out in the same manner, and streptovaricin C was separated from the adsorbent separated from the medium using the same solvent as in Example 1. It was confirmed that the solvent after washing contained 3.6 mg of streptovaricin C.
比較例2
発酵培地としてポリスチレン系吸着剤を含まない以外は
同一の組成である培地を使用した以外は、実施例2と同
様にして培養を行い、ストレプトバリシンCを培地およ
び菌体から分離した。ストレプトバリシンCが0.08
mg得られた。Comparative Example 2 Culture was carried out in the same manner as in Example 2, except that a medium with the same composition except that it did not contain a polystyrene adsorbent was used as the fermentation medium, and streptovaricin C was separated from the medium and the bacterial cells. . Streptovaricin C is 0.08
mg was obtained.
実施例3
実施例2において、培養後に発酵培地から分離されたポ
リスチレン系吸着剤に吸着されている物質中のストレプ
トバリシンCの割合は、高速液体クロマトグラフィーに
よる測定(254nmにおいて分析)によると、10重
量%であった。この吸着剤を15%アセトニ) IJル
水溶液で洗浄後、50%アセトニトリル水溶液で吸着物
質を溶出させた。溶出操作後の該アセトニトリル水溶液
を蒸発、乾固させたところ、得られた固形の粗生成物に
はストレプトバリシンCが50%含まれていた。Example 3 In Example 2, the proportion of streptovaricin C in the substance adsorbed on the polystyrene adsorbent separated from the fermentation medium after culturing was determined by high performance liquid chromatography (analyzed at 254 nm) as follows: It was 10% by weight. After washing this adsorbent with a 15% acetonitrile aqueous solution, the adsorbed material was eluted with a 50% acetonitrile aqueous solution. After the elution operation, the acetonitrile aqueous solution was evaporated to dryness, and the resulting solid crude product contained 50% streptovaricin C.
従来ストレプトマイセス属微生物の培養によっては極め
て少量のストレプトバリシンしか得ることができなかっ
たが、本発明の方法によれば10倍以上、特に好適実施
態様によれば20倍以上の効率でストレプトバリシンを
生産することができ、工業的にも実用性が極めて高い製
造方法である。Conventionally, only a very small amount of streptovaricin could be obtained by culturing Streptomyces microorganisms, but according to the method of the present invention, streptovaricin can be obtained with an efficiency of more than 10 times, and in a particularly preferred embodiment, more than 20 times. It is a manufacturing method that can produce baricin and is extremely practical from an industrial perspective.
Claims (2)
ン生産菌を、非イオン性吸着剤の存在下で培養する工程
を有するストレプトバリシンの製造方法。(1) A method for producing streptovaricin, which comprises the step of culturing streptovaricin-producing bacteria belonging to the genus Streptomyces in the presence of a nonionic adsorbent.
さらにフマル酸およびその水溶性塩からなる群から選ば
れる少なくとも1種が添加された培地で行われるストレ
プトバリシンの製造方法。(2) The method for producing streptovaricin according to claim (1), wherein the culturing is carried out in a medium further supplemented with at least one member selected from the group consisting of fumaric acid and a water-soluble salt thereof. .
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1428590A JPH0646950B2 (en) | 1990-01-24 | 1990-01-24 | Method for producing streptovaricin |
US07/601,875 US5126254A (en) | 1990-01-24 | 1990-10-23 | Process for preparation of streptovaricin |
US07/875,369 US5242815A (en) | 1990-01-24 | 1992-04-29 | Process for preparation of streptovaricin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1428590A JPH0646950B2 (en) | 1990-01-24 | 1990-01-24 | Method for producing streptovaricin |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH03219887A true JPH03219887A (en) | 1991-09-27 |
JPH0646950B2 JPH0646950B2 (en) | 1994-06-22 |
Family
ID=11856823
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1428590A Expired - Lifetime JPH0646950B2 (en) | 1990-01-24 | 1990-01-24 | Method for producing streptovaricin |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0646950B2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0538050A2 (en) * | 1991-10-16 | 1993-04-21 | SHIN-ETSU BIO, Inc. | Process for producing streptovaricin C |
EP0546819A1 (en) * | 1991-12-09 | 1993-06-16 | Shin-Etsu Chemical Co., Ltd. | Process for preparation of streptovaricin by fermentation |
JP2005246119A (en) * | 2004-03-01 | 2005-09-15 | Ebara Corp | Anaerobic treating method for polluted material containing oil and fat, and device therefor |
-
1990
- 1990-01-24 JP JP1428590A patent/JPH0646950B2/en not_active Expired - Lifetime
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0538050A2 (en) * | 1991-10-16 | 1993-04-21 | SHIN-ETSU BIO, Inc. | Process for producing streptovaricin C |
EP0538050A3 (en) * | 1991-10-16 | 1994-05-04 | Shinetsu Bio Inc | |
EP0546819A1 (en) * | 1991-12-09 | 1993-06-16 | Shin-Etsu Chemical Co., Ltd. | Process for preparation of streptovaricin by fermentation |
JP2005246119A (en) * | 2004-03-01 | 2005-09-15 | Ebara Corp | Anaerobic treating method for polluted material containing oil and fat, and device therefor |
JP4516330B2 (en) * | 2004-03-01 | 2010-08-04 | 荏原エンジニアリングサービス株式会社 | Method and apparatus for anaerobic treatment of oil-containing contaminants |
Also Published As
Publication number | Publication date |
---|---|
JPH0646950B2 (en) | 1994-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5106120B2 (en) | Method for producing ansamitocin | |
US20080050787A1 (en) | Method for Manufacturing Optically Active Tetrahydrothiophene Derivative and Method for Crystallization of Optically Active Tetrahydrothiophene-3-Ol | |
US4480033A (en) | Lankacidins production | |
JPH03219887A (en) | Production of stereptovaricin | |
US5126254A (en) | Process for preparation of streptovaricin | |
US5242815A (en) | Process for preparation of streptovaricin | |
JPH0226957B2 (en) | ||
GB2064517A (en) | Cephamycin compounds | |
JPS6324000B2 (en) | ||
JP2645680B2 (en) | Fermentation production method of streptovaricin | |
JP3067183B2 (en) | Method for producing FR900506 substance | |
US5188945A (en) | Recovery process for antibiotics ll-e19020 alpha and beta | |
JPH03219888A (en) | Production of streptovaricin | |
JPS6338038B2 (en) | ||
JPH10508476A (en) | Microbial conversion method to obtain antibiotic GE2270 factor D (2) | |
JPS6338039B2 (en) | ||
AU2012201869B2 (en) | Methods for the production of ansamitocins | |
JPH0822858B2 (en) | Novel antibiotic H9 and method for producing the same | |
WO1990004034A1 (en) | Increased rubradirin yields | |
JPS5927898A (en) | Novel antibiotic and its preparation | |
GB1562987A (en) | Process for preparing multhiomycin | |
JPH06105696A (en) | Production of tylonolide derivative | |
JPH05192176A (en) | Production of beta-rhodomycinone | |
JP2003012607A (en) | Novel mevastatin derivative | |
JPH0411556B2 (en) |